News
A larger role for China, perhaps, and the fraught issue of integrating HIV services into services for other diseases.
Discover how the WHO's new guidelines on lenacapavir could revolutionise HIV prevention, offering a long-acting alternative ...
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...
Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S.
The most common HIV antibody blood test is called an “A-0” test, which is available for approximately 70 cents in many low- ...
The Maine Center for Disease Control has identified two more positive HIV cases in Penobscot County, bringing the total cases ...
You can notice signs of HIV on the tongue during the early and late stages of the infection with the virus. An acute HIV ...
GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...
9d
Health on MSNHow HIV Can Affect Your Tongue and Oral HealthMedically reviewed by Renita White, MD Mouth and tongue lesions are often one of the first symptoms of human immunodeficiency ...
Baltimore's beloved live music tradition, Jazzy Summer Nights is well into its 25th and final season. This farewell season, ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results